Gebelik ve Emzirme Döneminde COVID-19 Enfeksiyonuna Karşı Aşılanma

Yıl 2022, , 1663 - 1668, 22.12.2022

Resmiye Kaya Odabaş , Rukiye Demir , Ayten Taşpınar

https://doi.org/10.37989/gumussagbil.943186

Öz

COVID-19 pandemisi ile mücadelede aşı önemli bir yer tutmaktadır. Ancak, aşının fetüs ve bebek üzerindeki bilinmeyen etkileri nedeniyle gebe ve emziren kadınlar aşılarla ilgili klinik deneylerin dışında tutulmuştur. Bu yüzden COVID-19 aşılarının gebelik ve emzirme döneminde kadınlar üzerindeki etkisi hakkında kanıtlar yetersiz olup, bu durum gebe ve emziren kadınlarda endişe ve kaygıya neden olmaktadır. Gebeler, yoğun bakım ünitesine yatış, mekanik ventilasyon ihtiyacı ve ölüm dâhil olmak üzere COVID-19 enfeksiyonunun ciddi sonuçları açısından normal popülasyona göre riskli grup olarak kabul edilse de aşılanma sürecinde öncelikli gruplar arasında yer almamakta, aşının yararının potansiyel riskten daha ağır bastığı durumlarda gebelerin kendi istekleri dahilinde aşılanması önerilmektedir. Benzer şekilde emziren kadınlarda COVID-19 aşılarının güvenliği, aşılanmanın anne sütüyle beslenen bebeğe ve laktasyona etkileri konusunda yeterli veri bulunmasa da emziren kadınlar veya bebekleri için bir risk oluşturmadığı bildirilmekte ve emziren kadınlara COVID-19 aşısı önerilmektedir. Aşılarla ilgili gebe ve emziren kadınların karar vermesinin desteklenmesi için aşılar hakkında kanıta dayalı ve kişiye özel bilgilere gerek vardır ve bu bilgiler ebe, hemşire ve hekim gibi sağlık profesyonelleri tarafından sağlanmalıdır. Bu bağlamda bu derleme, gebelik ve emzirme döneminde COVID-19 enfeksiyonuna karşı aşılanmayı bilimsel veriler ve literatür ışığında ele almak amacıyla yapılmıştır.

Anahtar Kelimeler

Gebelik, emzirme, Aşı, COVID-19

Destekleyen Kurum

yok

Vaccination Against Coronavirus Infection During Pregnancy and Breastfeeding Period

Öz

Vaccination plays an important role in combating the COVID-19 pandemic. However, pregnant women and lactating women are excluded from clinical trials of vaccines due to the unknown effects of the vaccine on the fetus and infant. Therefore, there is insufficient evidence about the effect of COVID-19 vaccines on women during pregnancy and the breastfeeding period which causes concern and anxiety among pregnant women and lactating women. Although pregnant women are considered to be a risk group compared to the normal population in terms the serious consequences of the infection, including hospitalization in the intensive care unit, need for mechanical ventilation and death, they are not among the priority groups in the vaccination process. In cases where the benefit of the vaccine outweighs the potential risk, it is recommended that pregnant women be vaccinated on their own will. Similarly, although there is insufficient data on the safety of COVID-19 vaccines among breastfeeding women and the effects of vaccination on breastfed babies and lactation, it is reported that COVID-19 vaccines do not pose a risk for breastfeeding women or their babies, and thus COVID-19 s vaccine is recommended for breastfeeding women. Evidence-based and personalized information about vaccines is needed to support pregnant and breastfeeding women's decision making about vaccines, and this information should be provided by health professionals such as midwife, nurse and physicians. In this context, this review was conducted to discuss vaccination against COVID-19 infection during pregnancy and the breastfeeding period based on scientific data and literature.

Anahtar Kelimeler

Pregnancy, Breastfeeding, Vaccine, COVID-19

Kaynakça

• 1. World Health Organization. (2020). “Novel Coronavirus (2019-nCoV) Situation Report – 1 21 January 2020”. Erişim adresi: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf (Erişim tarihi: 25.02.2022).
• 2. World Health Organization. (2020). “Director-General’s Remarks at The Media Briefing on 2019- Ncov On 11 February 2020”. Erişim adresi: https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (Erişim tarihi: 25.02.2022).
• 3. Ardıç, C, Uzun, K, Yazan Arslan, A, Şahin, A, Hür, M, Serçe, M.N, Türker, S, Usluoğlu B, Süzük, M. ve Sarimehmet, D. (2020). “COVID-19 Pandemic Process: Its Evaluation in Terms of Spreading Rate, Mortality Rate and Precautions Taken”. Ankara Med J, 20 (2), 370-379. https://doi.org/ 10.5505/amj.2020.05826
• 4. T.C. Sağlık Bakanlığı. (2021). “COVID-19 Bilgilendirme Platformu. Türkiye COVID-19 Hasta Tablosu, 17.07.2022”. Erişim adresi: https://covid19.saglik.gov.tr/ (Erişim tarihi: 18.07.2022).
• 5. T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. (2020). “COVID-19 (SARS-CoV Enfeksiyonu) Rehberi”. Erişim adresi: https://hastane.deu.edu.tr/images/hastanemizden-haberler/corona/COVID 19_Rehberii.pdf (Erişim tarihi: 25.02.2022).
• 6. Çelik, D. ve Köse, Ş. (2020). “Erişkinlerde COVID-19: Klinik Bulgular”. Tepecik Eğit. ve Araşt. Hast. Dergisi, 30 (Ek sayı), 43-48. https://doi.org/ 10.5222/terh.2020.88896
• 7. Kingsley, J.P, Kingsley Vijay, P, Kumaresan, J. and Sathiakumar, N. (2021). “The Changing Aspects of Motherhood in Face of The COVID-19 Pandemic in Low- and Middle-Income Countries”. Matern Child Health J, 25 (1), 15–21. https://doi.org/10.1007/s10995-020-03044-9.
• 8. Centers for Disease Control and Prevention. (2020). “Information About COVID-19 Vaccines for People Who are Pregnant or Breastfeeding”. Erişim adresi: https://www.cdc.gov/coronavirus/2019ncov/vaccines/recommendations/pregnancy.html#:~:text=Therefore%2C%20lactating%20people%20can%20receive,may%20provide%20to%20the%20baby (Erişim tarihi: 15.05.2021).
• 9. Allotey, J, Stallings, E, Bonet, M, Yap, M, Chatterjee, S, Kew, J, Debenham, L, Clavé Llavall, A, Dixit, A, Zhou, A, Balaji, R, Lee, S.I, Qiu, X, Yuan, M, Coomar, D, Sheikh, J, Lawson, H, Ansari, K, Wely, M, Leeuwen, E, Kostava, E, Kunst, H, Khalil, A, Tiberi, S, Brizuela, V, Broutet, N, Kara, E, Kim, C.R, Thorsan, A, Oladapu, O, Mofenson, O, Zamora, J. and Thangaratinam, S. (2020). “Clinical Manifestations, Risk Factors and Maternal and Perinatal Outcomes of Coronavirus Disease 2019 in Pregnancy: Living Systematic Review and Meta-Analysis”. BMJ, 370 (m3320), 1-18. doi: 10.1136/bmj.m3320.
• 10. Kotlyar, A.M, Grechukhina, O, Chen, A, Popkhadze, S, Grimshaw, A, Tal, O, Taylor, H.S. and Tal, S. (2021). “Vertical Transmission of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis”. Am J Obstet Gynecol, 224 (1), 35–53. https://doi.org/10.1016/j.ajog.2020.07.049.
• 11. Chambers, C, Krogstad, P. and Bertrand, K. (2020). “Evaluation for SARS-Cov-2 in Breast Milk From 18 Infected Women”. JAMA, 324 (13), 1347–1348. https://doi.org/ 10.1001/jama.2020.15580
• 12. Anderson, R.M, Vegvari, C, Trustcott, J. and Collyer, B.J. (2020). “Challenges in Creating Herd Immunity To SARS-Cov-2 Infection By Mass Vaccination”. Lancet, 396 (4), 1614–1616. https://doi.org/10.1016/S0140-6736(20)32318-7.
• 13. Mello, M.M, Silverman, R.D. and Omer, S.B. (2020). “Ensuring Uptake of Vaccines Against SARS-Cov-2”. The New England Journal of Medicine, 383, 1296–1299.
• 14. T.C. Sağlık Bakanlığı. (2021). “COVID-19 Bilgilendirme Platformu. Aşı Uygulanacak Grup Sıralaması”. Erişim adresi: https://covid19asi.saglik.gov.tr/TR-77707/asi-uygulanacak-grup-siralamasi.html (Erişim tarihi: 25.02.2022).
• 15. United States Food and Drug Administration. (2022). “Emergency use authorization”. Erişim adresi: https://www.fda.gov/emergency-preparednessandresponse/mcm legal-regulatory-and-policyframework/emergency-use-authorization (Erişim tarihi: 25.02.2022).
• 16. Rasmussen, S.A, Kelley, C.F. and Jamieson, D. (2021). “Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy”. Obstetrics and Gynecology, 137 (3), 408-414. https://doi.org/10.1097/AOG.0000000000004290.
• 17. Royal College of Obstetrıcs and Gynecology. (2021). “COVID-19 Vaccines, Pregnancy and Breastfeeding 2021”. Erişim adresi: https://www.rcog.org.uk/en/guidelines-research-services/coronavirus-covid-19-pregnancy-and-womens-health/covid-19-vaccines-and-pregnancy/covid-19-vaccines-pregnancy-and-breastfeeding/ (Erişim tarihi: 25.02.2022).
• 18. Krammer, F. (2020). “SARS-CoV-2 Vaccines in Development”. Nature, 586 (7830), 516–27. https://doi.org/10. 1038/s41586-020-2798-3
• 19. T.C. Sağlık Bakanlığı. (2022). “COVID-19 Bilgilendirme Platformu. Türkiye Aşı Tablosu”. Erişim adresi: https://covid19asi.saglik.gov.tr/?gclid=CjwKCAjwqIiFBhAHEiwANg9szv24CGPoOjKAtTrRjO2uzcy31Sldt5Rb_ivcoZTRhk2Bpb00M9qCMRoCRQ4QAvD_BwE (Erişim tarihi: 28.07.2022).
• 20. T.C. Sağlık Bakanlığı. (2021). “COVID-19 Bilgilendirme Platformu. COVID-19 Aşısı Aşı Uygulanacak Grup Sıralaması”. Erişim adresi: https://covid19asi.saglik.gov.tr/TR-77707/asi-uygulanacak-grup-siralamasi.html (Erişim tarihi: 25.02.2021).
• 21. Chen, H, Guo, J, Wang, C, Luo, F, Yu, X, Zhang, W, Li, J, Zhao, D, Xu, D, Gong, Q, Liao, J, Yang, H, Hou, W. and Zhang, Y. (2021). “Clinical Characteristics and Intrauterine Vertical Transmission Potential of COVID-19 Infection in Nine Pregnant Women: A Retrospective Review of Medical Records”. Lancet, 395 (10226), 809-815. https://doi.org/10.10 16/S0140-6736(20)30360-3
• 22. Ellington, S, Strid, P, Tong, V.T, Woodworth, K, Galang, R.R, Zambrano, L.D, Nahabedian, J, Anderson, K. and Gilboa, S.M. (2020). “Characteristics of Women of Reproductive Age With Laboratory-Confirmed SARS-Cov-2 Infection by Pregnancy Status—United States, January 22–June 7, 2020”. Morbidity and Mortality Weekly Report, 69 (25), 769-775. http://dx.doi.org/10.15585/mmwr.mm6925a1
• 23. Pirjani, R, Hosseini, R, Soori, T, Rabiei, M, Hosseini, L, Abiri, A, Moini, A, Shizarpour, A, Razani, G. and Sepidarkish, M. (2020). “Maternal and Neonatal Outcomes in COVID-19 Infected Pregnancies: A Prospective Cohort Study”. J Travel Med, 9 (27), 1-19. https://doi.org/10.1093/jtm/taaa158.
• 24. Dubey, P, Reddy, S.Y, Manuel, S. and Dwivedi, A.K. (2020). “Maternal and Neonatal Characteristics and Outcomes Among COVID-19 Infected Women: An Updated Systematic Review and Meta-Analysis”. Eur. J. Obstet. Gynecol. Reprod. Biol, 252, 490–501. https://doi.org/10.1016/j.ejogrb.2020.07.034.
• 25. World Health Organization. (2020). “WHO Sage Roadmap For Prioritizing Uses of Covıd-19 Vaccines in The Context of Limited Supply”. Erişim adresi: https://www.who.int/publications/m/item/who-sage-roadmap-for prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply (Erişim tarihi: 12.05.2021).
• 26. Shimabukuro, T.T, Kim, S.Y, Myers, T.R, Moro, P.L, Oduyebo, M, Panagiotakopoulos, L, Marquez, P.L, Olson, C.K, Liu, R, Chang, K.T, Ellington, R.S, Burkel, V.K, Smoots, A.N, Green, C.J, Licata, C. Zhang, B.C, Alimchandani, M, Mba-Jonas, A, Martin, S.W, Gee, J.M. and Meaney-Delman, D.M. (2021). “Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons”. The New England Journal of Medicine, 5 (1), 1-10. https://doi.org/10.1056/NEJMoa2104 983.
• 27. American College of Obstetricians and Gynecologists. “Vaccinating Pregnant and Lactationg Patients Against COVID-19. December 13 2020”. (2020). Erişim adresi: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19 (Erişim tarihi: 17.02.2022).
• 28. The Royal College of Obstetricians and Gynaecologists. (2021). “Coronavirus (COVID-19) Infection in Pregnancy, Information for Healthcare Professionals, Version 13. 19 February 2021”. Erişim adresi: https://www.rcog.org.uk/globalassets/documents/guidelines/2021-02-19-coronavirus-covid-19-infection-in-pregnancy-v13.pdf (Erişim tarihi: 05.2021).
• 29. World Health Organization. (2021). “Information for the public: COVID-19 vaccines”. Erişim adresi: https://www.who.int/westernpacific/emergencies/covid19/information-vaccines (Erişim tarihi: 21.02.2022).
• 30. T.C. Sağlık Bakanlığı. (2021). “COVID-19 Aşısı Bilgilendirme Platformu. İnaktif COVID-19 aşısı gebelere uygulanabilir mi?” Erişim adresi: https://covid19asi.saglik.gov.tr/TR-85117/16-inaktif-covid-19-asisi-gebelere-uygulanabilir-mi.html. (Erişim tarihi: 21.02.2022).
• 31. Ceulemans, M, Foulon, V, Panchaud, A, Winterfeld, U, Pomar, L, Lambelet, V, Cleary, B, O'Shaughnessy, F, Passier, A, Richardson, A.J, Allegaert, K. and Nordeng, H. (2021). “Vaccine Willingness and Impact of The COVID-19 Pandemic on Women’s Perinatal Experiences and Practices—A Multinational, Cross-Sectional Study Covering The First Wave of The Pandemic”. Int. J. Environ. Res. Public Health, 18, 367, 1-14. https://doi.org/10.3390/ijerph18073367.
• 32. Goncu Ayhan, Ş, Oluklu, D, Atalay, A, Menekşe Beşer, D, Tanacan, A, Moraloğlu Tekin, Ö. and Şahin, D. (2021). “COVID-19 Vaccine Acceptance in Pregnant Women”. J Gynecol Obstet, 00: 1–6. https://doi.org/10.1002/ijgo.13713.
• 33. Wang, L, Shi, L, Xiao, T, Fu, J, Feng, X, Mu, D, Feng, Q, Hei, M, Hu, X, Li, Z, Lu, G, Tang, Z, Wang, Y, Wang, C, Xia, S, Xu, J, Yang, Y, Yang, J, Zeng, M, Zheng, J, Zhou, W, Zhou, X, Zhou, X, Du, L, Lee, S.K, Shoo K. and Zhou, W. (2020). “Chinese Expert Consensus on The Perinatal and Neonatal Management for The Prevention and Control of The 2019 Novel Coronavirus Infection”. Annals of Translational Medicine, 8 (3), 47-55. https://doi.org/10.21037/atm.2020.02. 20
• 34. Davanzo, R, Moro, G, Sandri, F, Agosti, M, Moretti, C. and Mosca, F. (2020). “Breastfeeding and Coronavirus Disease-2019: Ad Interim Indications of The Italian Society of Neonatology Endorsed by The Union of European Neonatal & Perinatal Societies”. Matern Child Nutr, 16 (3), 1-18. https://doi.org/10.1111/mcn.13010.
• 35. World Health Organization (WHO). (2020). “Breastfeeding and COVID-19”. Erişim adresi: https://www.who.int/news-room/commentaries/detail/breastfeeding-and-covid-19 (Erişim tarihi: 12.05.2021).
• 36. Centeno‐Tablante, E, Medina-Rivera, M, Finkelstein, J.L, Rayco-Solon, P, Garcia-Casal, M.N, Rogers, L, Ghezzi-Kopel, K, Ridwan, P, Peña-Rosas, J.P. and Mehta, S. (2021). “Transmission of SARS‐Cov‐2 Through Breast Milk and Breastfeeding: A Living Systematic Review”. Annals of the New York Academy of Sciences, 1484 (1), 32–54. https://doi.org/10.1111/nyas.14477.
• 37. Lebrão, C.W, Navarro Cruz, N, Henrique da Silva, M, Veríssimo Dutra, L, Cristiani, C, Affonso Fonseca, F.L. and Suano-Souza, F.I. (2020). “Early Identification of Iga Anti-Sarscov-2 in Milk of Mother With COVID-19 Infection”. Journal of Human Lactation, 36(4), 609–613. https://doi.org/10.1177/0890334420960433 32985922.
• 38. Lubbe, W, Botha, E, Niela-Vilen, H. and Reimers, P. (2020). “Breastfeeding During The COVID-19 Pandemic: A Literature Review For Clinical Practice”. International Breastfeeding Journal, 15 (82), 1-9. https://doi.org/10.1186/s13006-020-00319-3 32928250.
• 39. Centers for Disease Control and Prevention (2022). “COVID-19 Vaccines While Pregnant or Breastfeeding”. Erişim adresi: https://www.cdc.gov/coronavirus/2019ncov/vaccines/recommendations/pregnancy.html#:~:text=COVID19%20vaccination%20is%20recommended,it's%20time%20to%20get%20one (Erişim tarihi: 15.02.2022).